XNCR · Xencor, Inc.
AI read · Good for XNCR
The AI's read
Analysts' favorable views and reported study results support confidence in the drug candidate. The story gives no study measurements or proof of approval or sales.
Analysts Update Price Targets and Ratings for Xencor
Good for XNCR
Four firms kept positive ratings, with price targets from $40 to $45 after analysts said XmAb819 data exceeded expectations. The report gives no trial figures or approval news, but the analyst support and reported results favor Xencor.
Get alerts for XNCR
Follow Xencor, Inc. (XNCR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for XNCRFree on the App Store and Google Play, or on the web.